Jacco Wallinga
Hoogleraar Mathematische modellering van infectieziekten
- Naam
- Prof.dr. J. Wallinga
- Telefoon
- +31 71 526 9111
- j.wallinga@lumc.nl
- ORCID iD
- null
Jacco Wallinga is bijzonder hoogleraar mathematische modellering van infectieziekten. Daarnaast is hij verbonden aan het RIVM als hoofd van de afdeling Modellering van Infectieziekten.
Meer informatie over Jacco Wallinga
Jacco Wallinga is bijzonder hoogleraar mathematische modellering van infectieziekten. Daarnaast is hij verbonden aan het RIVM als hoofd van de afdeling Modellering van Infectieziekten.
Bestrijding van infectieziekten
Hoe kunnen we de verspreiding van een infectieziekte onder de bevolking voorspellen? En als we maatregelen willen nemen om dit te stoppen, hoe effectief moeten die maatregelen zijn? Hoeveel levens worden gered door het huidig vaccinatieprogramma? Deze vragen staan centraal in het onderzoek voor infectieziektebestrijding. Met wiskundige, statistische en computationele methoden beantwoorden we deze vragen.
Wetenschappelijke carrière
Jacco Wallinga deed zijn opleiding en zijn promotieonderzoek aan de Wageningen Universiteit. De titel van zijn proefschrift (11 december 1998) luidt ‘Dynamics of Weed Populations: spatial pattern formation and implications for control’. Vervolgens specialiseerde Wallinga zich verder in de populatiebiologie van infectieziekten bij het Rijksinstituut voor Volksgezondheid en Milieu (RIVM). Hij werd in 2015 benoemd tot bijzonder hoogleraar mathematische modellering van infectieziekten van het Leids Universiteit Medisch Centrum. De titel van zijn oratie is ‘De epidemie voorbij: rekenmodellen voor infectieziektebestrijding’ (21 oktober 2016).
Wallinga heeft ruim 100 wetenschappelijke publicaties en boekhoofdstukken op zijn naam staan (zie ook de website van Harvard - School of Public Health).
In het verleden was onder andere lid van Gezondheidsraad-commissies.
Wallinga zat in de redactieraad van het tijdschrift Epidemiology. Hij adviseert diverse nationale overheden en organisaties (zoals de WHO).
Hoogleraar Mathematische modellering van infectieziekten
- Faculteit Geneeskunde
- Divisie 4
- Biomedical Data Sciences
- Konstantinovski, M.; Geest, C. van; Bruijning, M.; Keizer, L.K.D.; Wallinga, J.; Burgel, N. van & Veldkamp, K.E. (2024), Rate of nosocomial MRSA transmission evaluated via contact screening, Antimicrobial Resistance and Infection Control 13(1).
- Xiridou, M.; Heijne, J.; Adam, P.; Coul, E.O. de; Matser, A.; Wit, J. de; Wallinga, J. & Benthem, B. van (2022), How the disruption in sexually transmitted infection care due to the COVID-19 Pandemic could lead to increased sexually transmitted infection transmission among men who have sex with men in The Netherlands , Sexually Transmitted Diseases 49(2): 145-153.
- Miura, F.; Ewijk, C.E. van; Backer, J.A.; Xiridou, M.; Franz, E.; Coul, E.O. de; Brandwagt, D.; Cleef, B. van; Rijckevorsel, G. van; Swaan, C.; Hof, S. van den & Wallinga, J. (2022), Estimated incubation period for monkeypox cases confirmed in the Netherlands, May 2022, Eurosurveillance 27(24).
- Ainslie, K.E.C.; Backer, J.A.; Boer, P.T. de; Hoek, A.J. van; Klinkenberg, D.; Altes, H.K.; Leung, K.Y.; Melker, H. de; Miura, F. & Wallinga, J. (2022), A scenario modelling analysis to anticipate the impact of COVID-19 vaccination in adolescents and children on disease outcomes in the Netherlands, summer 2021, Eurosurveillance 27(44): 28-37.
- McDonald, S.A.; Lagerweij, G.R.; Boer, P. de; Melker, H.E. de; Pijnacker, R.; Gras, L.M.; Kretzschmar, M.E.; Hartog, G. den; Gageldonk-Lafeber, A.B. van; Hof, S. van den; Wallinga, J. & RIVM COVID-19 Surveillance Epidemi (2022), The estimated disease burden of acute COVID-19 in the Netherlands in 2020, in disability-adjusted life-years, European Journal of Epidemiology 37(10): 1035-1047.
- McDonald, S.A.; Wijhe, M. van; Gier, B. de; Altes, H.K.; Vlaminckx, B.J.M.; Hahne, S. & Wallinga, J. (2022), The dynamics of scarlet fever in The Netherlands, 1906-1920, Royal Society Open Science 9(11).
- Klinkenberg, D.; Hoek, A.J. van; Veldhuijzen, I.; Hahne, S. & Wallinga, J. (2022), Social clustering of unvaccinated children in schools in the Netherlands, Epidemiology & Infection 150.
- Backer, J.A.; Eggink, D.; Andeweg, S.P.; Veldhuizen, I.K.; Maarseveen, N. van; Vermaas, K.; Vlaemynck, B.; Schepers, R.; Hof, S. van den; Reusken, C.B.E.M. & Wallinga, J. (2022), Shorter serial intervals in SARS-CoV-2 cases with Omicron BA.1 variant compared with Delta variant, the Netherlands, 13 to 26 December 2021, Eurosurveillance: Europe's journal on infectious disease surveillance, epidemiology, prevention and control 27(6).
- Hoogink, J.; Verelst, F.; Kessels, R.; Hoek, A.J. van; Timen, A.; Willem, L.; Beutels, P.; Wallinga, J. & Wit, G.A. de (2020), Preferential differences in vaccination decision-making for oneself or one's child in The Netherlands, BMC Public Health 20(1).
- Boer, P.T. de; Backer, J.A.; Hoek, A.J. van & Wallinga, J. (2020), Vaccinating children against influenza, BMC Medicine 18(1).
- Reitsema, M.; Hoek, A.J. van; Loeff, M.S. van der; Hoornenborg, E.; Sighem, A. van; Wallinga, J.; Benthem, B. van & Xiridou, M. (2020), Preexposure prophylaxis for men who have sex with men in the Netherlands, AIDS 34(4): 621-630.
- Gostic, K.M.; McGough, L.; Baskerville, E.B.; Abbott, S.; Joshi, K.; Tedijanto, C.; Kahn, R.; Niehus, R.; Hay, J.A.; Salazar, P.M. de; Hellewell, J.; Meakin, S.; Munday, J.D.; Bosse, N.I.; Sherrat, K.; Thompson, R.N.; White, L.F.; Huisman, J.S.; Scire, J.; Bonhoeffer, S.; Stadler, T.; Wallinga, J.; Funk, S.; Lipsitch, M. & Cobey, S. (2020), Practical considerations for measuring the effective reproductive number, R-t, PLoS Computational Biology 16(12).
- Backer, J.A.; Klinkenberg, D. & Wallinga, J. (2020), Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20-28 January 2020, Eurosurveillance 25(5): 10-15.
- Reitsema, M.; Heijne, J.; Visser, M.; Sighem, A. van; Loeff, M.S. van der; Coul, E.L.M. op de; Bezemer, D.; Wallinga, J.; Benthem, B.H.B. van & Xiridou, M. (2020), Impact of frequent testing on the transmission of HIV andN. gonorrhoeaeamong men who have sex with men, Sexually Transmitted Infections 96(5): 361-367.
- Tindale, L.C.; Stockdale, J.E.; Coombe, M.; Garlock, E.S.; Lau, W.Y.V.; Saraswat, M.; Zhang, L.X.; Chen, D.X.; Wallinga, J. & Colijn, C. (2020), Evidence for transmission of COVID-19 prior to symptom onset, eLife 9.
- Ganyani, T.; Kremer, C.; Chen, D.X.; Torneri, A.; Faes, C.; Wallinga, J. & Hens, N. (2020), Estimating the generation interval for coronavirus disease (COVID-19) based on symptom onset data, march 2020, Eurosurveillance 25(17): 12-19.
- Dam, A.S.G. van; Woudenberg, T.; Melker, H.E. de; Wallinga, J. & Hahne, S.J.M. (2020), Effect of vaccination on severity and infectiousness of measles during an outbreak in the Netherlands, 2013-2014, Epidemiology & Infection 148.
- Gaalen, R.D. van; Altorf-van der Kuil, W.; Wegdam-Blans, M.C.A.; Diaz, J.M.A.; Beauchamp, M.E.; Pinedo, L.E.C.; Greeff, S.C. de & Wallinga, J. (2020), Determination of the time-dependent association between ciprofloxacin consumption and ciprofloxacin resistance using a weighted cumulative exposure model compared with standard models, Journal of Antimicrobial Chemotherapy 75(8): 2326-2333.
- Kremer, C.; Ganyani, T.; Chen, D.X.; Torneri, A.; Faes, C.; Wallinga, J. & Hens, N. (2020), Authors' response: estimating the generation interval for COVID-19 based on symptom onset data.
- Asmuth, E.G.J. von; Brockhoff, H.J.; Wallinga, J. & Visser, L.G. (2019), S. typhi Vi capsular polysaccharide vaccine-induced humoral immunity in travellers with immunosuppressive therapy for rheumatoid disease, Journal of Travel Medicine 26(1).
- Uzorka, J.W.; Wallinga, J.; Kroft, L.J.M.; Ottenhoff, T.H.M. & Arend, S.M. (2019), Radiological Signs of Latent Tuberculosis on Chest Radiography: A Systematic Review and Meta-Analysis, Open Forum Infectious Diseases 6(7).
- Kassteele, J. van de; Eilers, P.H.C. & Wallinga, J. (2019), Nowcasting the Number of New Symptomatic Cases During Infectious Disease Outbreaks Using Constrained P-spline Smoothing, Epidemiology 30(5): 737-745.
- Asmuth, E.G.J. von; Brockhoff, H.J.; Wallinga, J. & Visser, L.G. (2019), S. typhi Vi capsular polysaccharide vaccine-induced humoral immunity in travellers with immunosuppressive therapy for rheumatoid disease, Journal of Travel Medicine 26(1).
- Soetens, L.; Backer, J.A.; Hahne, S.; Binnendijk, R. van; Gouma, S. & Wallinga, J. (2019), Visual tools to assess the plausibility of algorithm-identified infectious disease clusters: an application to mumps data from the Netherlands dating from January 2009 to June 2016, Eurosurveillance 24(12): 26-36.
- Backer, J.A.; , M. van boven; Hoek, W. van der & Wallinga, J. (2019), Vaccinating children against influenza increases variability in epidemic size, Epidemics 26: 95-103.
- Wijhe, M. van; Boer, P.T. de; Jong, H.J. de; Vliet, H. van; Wallinga, J. & Postma, M.J. (2019), Trends in governmental expenditure on vaccination programmes in the Netherlands, a historical analysis, Vaccine 37(38): 5698-5707.
- Backer, J.A.; Wallinga, J.; Meijer, A.; Donker, G.A.; Hoek, W. van der & , M. van boven (2019), The impact of influenza vaccination on infection, hospitalisation and mortality in the Netherlands between 2003 and 2015, Epidemics 26: 77-85.
- Hoang, T.; Coletti, P.; Melegaro, A.; Wallinga, J.; Grijalva, C.G.; Edmunds, J.W.; Beutels, P. & Hens, N. (2019), A Systematic Review of Social Contact Surveys to Inform Transmission Models of Close-contact Infections, Epidemiology 30(5): 723-736.
- Peppel, R.J. van de; Beek, M.T. van der; Visser, L.G.; Boer, M.G.J. de & Wallinga, J. (2019), Managing invasive aspergillosis in haematological patients in the era of resistance polymerase chain reaction and increasing triazole resistance: A modelling study of different strategies, International Journal of Antimicrobial Agents 53(3): 284-293.
- Man, I.; Auranen, K.; Wallinga, J. & Bogaards, J.A. (2019), Capturing multiple-type interactions into practical predictors of type replacement following human papillomavirus vaccination, Philosophical Transactions B: Biological Sciences 374(1773).
- Klinkenberg, D.; Hahne, S.J.M.; Woudenberg, T. & Wallinga, J. (2018), The Reduction of Measles Transmission During School Vacations, Epidemiology 29(4): 562-570.
- Soetens, L.; Klinkenberg, D.; Swaan, C.; Hahne, S. & Wallinga, J. (2018), Real-time Estimation of Epidemiologic Parameters from Contact Tracing Data During an Emerging Infectious Disease Outbreak, Epidemiology 29(2): 230-236.
- Wijhe, M. van; Tulen, A.D.; Altes, H.K.; McDonald, S.A.; Melker, H.E. de; Postma, M.J. & Wallinga, J. (2018), Quantifying the impact of mass vaccination programmes on notified cases in the Netherlands, Epidemiology and Infection 146(6): 716-722.
- Wallinga, J. (2018), Metropolitan versus small-town influenza, Science 362(6410): 29-30.
- Wijn, D.H.; Groeneveld, G.H.; Vollaard, A.M.; Muller, M.; Wallinga, J.; Gelderblom, H. & Smit, E.F. (2018), Influenza vaccination in patients with lung cancer receiving anti-programmed death receptor 1 immunotherapy does not induce immune-related adverse events, European Journal of Cancer 104: 182-187.
- Man, I.; Wallinga, J. & Bogaards, J.A. (2018), Inferring Pathogen Type Interactions Using Cross-sectional Prevalence Data: Opportunities and Pitfalls for Predicting Type Replacement, Epidemiology 29(5): 666-674.
- Wijhe, M. van; McDonald, S.A.; Melker, H.E. de; Postma, M.J. & Wallinga, J. (2018), Estimating the Population-Level Effectiveness of Vaccination Programs in the Netherlands, Epidemiology 29(2): 215-223.
- Monge, S.; Benschop, K.; Soetens, L.; Pijnacker, R.; Hahne, S.; Wallinga, J. & Duizer, E. (2018), Echovirus type 6 transmission clusters and the role of environmental surveillance in early warning, the Netherlands, 2007 to 2016, Eurosurveillance 23(45): 11-20.
- Winter, A.K.; Martinez, M.E.; Cutts, F.T.; Moss, W.J.; Ferrari, M.J.; McKee, A.; Lessler, J.; Hayford, K.; Wallinga, J. & Metcalf, C.J.E. (2018), Benefits and Challenges in Using Seroprevalence Data to Inform Models for Measles and Rubella Elimination, Journal of Infectious Diseases 218(3): 355-364.
- Gaalen, R.D. van; Kassteele, J.V. van de; Hahne, S.J.M.; Bruijning-Verhagen, P. & Wallinga, J. (2017), Determinants of Rotavirus Transmission A Lag Nonlinear Time Series Analysis, Epidemiology 28(4): 503-513.
- Klinkenberg, D.; Backer, J.A.; Didelot, X.; Colijn, C. & Wallinga, J. (2017), Simultaneous inference of phylogenetic and transmission trees in infectious disease outbreaks, PLoS Computational Biology 13(5).
- Worby, C.J.; Wallinga, J.; Lipsitch, M. & Goldstein, E. (2017), Population effect of influenza vaccination under co-circulation of non-vaccine variants and the case for a bivalent A/H3N2 vaccine component, Epidemics 19: 74-82.
- Woudenberg, T.; Binnendijk, R.S. van; Sanders, E.A.M.; Wallinga, J.; Melker, H.E. de; Ruijs, W.L.M. & Hahne, S.J.M. (2017), Large measles epidemic in the Netherlands, May 2013 to March 2014: changing epidemiology, Eurosurveillance 22(3): 11-19.
- Soetens, L.; Hahne, S. & Wallinga, J. (2017), Dot map cartograms for detection of infectious disease outbreaks: an application to Q fever, the Netherlands and pertussis, Germany, Eurosurveillance 22(26): 23-29.
- Xiridou, M.; Lugner, A.; Vries, H.J.C. de; Bergen, J.E.A.M. van; Gotz, H.M.; Benthem, B.H.B. van; Wallinga, J. & Sande, M.A.B. van der (2016), Cost-Effectiveness of Dual Antimicrobial Therapy for Gonococcal Infections Among Men Who Have Sex With Men in the Netherlands, Sexually Transmitted Diseases 43(9): 542-548.
- Afdelingshoofd Modellering van Infectieziekten